港股药品股全线走强,其中,三生制药大涨超30%,石药集团涨超6%,香港医药ETF(513700)大涨3.78%,自4月9日以来累计涨超19%。消息面上,辉瑞与三生制药就PD-1/VEGF双特异性抗体SSGJ-707达成首付12.5亿美元,总额60.5亿美元的全球开发与商业化协议(除中国内地外),占三生制药市值的1/3,并对三生制药进行1亿美元股权投资和中国商业化选择权。4月中贸易摩擦以来,中国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.